El Salvador Vaccine Industry Outlook 2024 - 2028

See how El Salvador Vaccine performed compared to key markets.

Key Market Indicators

Salvadoran Vaccination Coverage is projected to decline to 75 percent for children aged 1 by 2028, down from 79 percent in 2023. This marks an average annual decrease of 0.8 percentage points. Historical data reveals a consistent decline in vaccination rates, with a yearly drop of 1 percentage point since 1985. In contrast, Salvadoran vaccine imports are on the rise. By 2028, imports are expected to reach approximately $19.6 million, up from $17.4 million in 2023. This represents an average annual growth rate of 1.8 percent. Looking back to 1999, the demand for vaccines in El Salvador has surged by 6.2 percent annually. Supply has also seen a dramatic increase. Since 2001, the Salvadoran vaccine supply has grown by 95.5 percent year on year.

El Salvador Vaccine Market Data and Forecasts

How much will El Salvador Vaccine Market grow to 2028?

Forecast: Import of Vaccines for Human Use to El Salvador
Forecast: Import of Vaccines for Human Use to El Salvador

Other Top Countries about Vaccine